| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 16967 | 2014 |
| Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Prospective Studies Collaboration The Lancet 360 (9349), 1903-1913, 2002 | 15074 | 2002 |
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance J Tuomilehto, J Lindström, JG Eriksson, TT Valle, H Hämäläinen, ... New England journal of medicine 344 (18), 1343-1350, 2001 | 15058 | 2001 |
| Analysis of protein-coding genetic variation in 60,706 humans M Lek, KJ Karczewski, EV Minikel, KE Samocha, E Banks, T Fennell, ... Nature 536 (7616), 285-291, 2016 | 10360 | 2016 |
| Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The lancet 390 (10113), 2627-2642, 2017 | 8165 | 2017 |
| Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol B Dahlöf, RB Devereux, SE Kjeldsen, S Julius, G Beevers, U de Faire, ... The Lancet 359 (9311), 995-1003, 2002 | 7901 | 2002 |
| Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project RM Conroy, K Pyörälä, AP Fitzgerald, S Sans, A Menotti, G De Backer, ... European heart journal 24 (11), 987-1003, 2003 | 7769 | 2003 |
| The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men HM Lakka, DE Laaksonen, TA Lakka, LK Niskanen, E Kumpusalo, ... Jama 288 (21), 2709-2716, 2002 | 7302 | 2002 |
| Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Prospective Studies Collaboration The Lancet 373 (9669), 1083-1096, 2009 | 6188 | 2009 |
| Dapagliflozin and cardiovascular outcomes in type 2 diabetes SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ... New England Journal of Medicine 380 (4), 347-357, 2019 | 6059 | 2019 |
| Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants NCD Risk Factor Collaboration Lancet (London, England) 387 (10026), 1377, 2016 | 5720 | 2016 |
| Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian … PS Sever, B Dahlöf, NR Poulter, H Wedel, G Beevers, M Caulfield, ... The Lancet 361 (9364), 1149-1158, 2003 | 5674 | 2003 |
| Telmisartan, ramipril, or both in patients at high risk for vascular events Ontarget Investigators New England Journal of Medicine 358 (15), 1547-1559, 2008 | 4937 | 2008 |
| Genetic studies of body mass index yield new insights for obesity biology AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ... Nature 518 (7538), 197-206, 2015 | 4750 | 2015 |
| Treatment of hypertension in patients 80 years of age or older NS Beckett, R Peters, AE Fletcher, JA Staessen, L Liu, D Dumitrascu, ... New England Journal of Medicine 358 (18), 1887-1898, 2008 | 4666 | 2008 |
| Age-related clonal hematopoiesis associated with adverse outcomes S Jaiswal, P Fontanillas, J Flannick, A Manning, PV Grauman, BG Mar, ... New England Journal of Medicine 371 (26), 2488-2498, 2014 | 4437 | 2014 |
| Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension JA Staessen, R Fagard, L Thijs, H Celis, GG Arabidze, WH Birkenhäger, ... The Lancet 350 (9080), 757-764, 1997 | 4312 | 1997 |
| Biological, clinical and population relevance of 95 loci for blood lipids TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ... Nature 466 (7307), 707-713, 2010 | 4087 | 2010 |
| Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial S Julius, SE Kjeldsen, M Weber, HR Brunner, S Ekman, L Hansson, ... The Lancet 363 (9426), 2022-2031, 2004 | 3932 | 2004 |
| Follow-up report on the diagnosis of diabetes mellitus S Genuth, K Alberti, P Bennett, J Buse, R DeFronzo, R Kahn, J Kitzmiller, ... Diabetes care 26 (11), 3160-3168, 2003 | 3829 | 2003 |
